Product Information

EUCRISA 2% OINTMENT is a brand product labeled by Pfizer Inc., priced at $12.6535 per GM under NDC 55724021121. Its NADAC has been published 501 times since Apr 19, 2017.

FDA first approved this application on Dec 14, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

EUCRISA 2% OINTMENT

crisaborole
$12.6535per GM

Strength

20 mg/g

Manufacturer

Pfizer Inc.

NDC

55724021121

Classification

Brand

Dosage Form

OINTMENT

Route

TOPICAL

Effective Date

11/18/2026

Active Ingredients

CRISABOROLE

Approval Type

New Drug (NDA)

FDA Application

NDA207695

FDA Approved

12/14/2016

TE Code

AB

On Market Since

1/30/2017

Pharmacological Classes

Phosphodiesterase 4 Inhibitor
Phosphodiesterase 4 Inhibitors

Price Statistics

The NADAC for EUCRISA 2% OINTMENT has been published 501 times since Apr 19, 2017, and over the history we have for it it has risen 35.2%. The table below summarizes its recorded NADAC range and movement.

Current price$12.6535 per GM
All-time high$12.6872 (May 14, 2025)
All-time low$9.3589 (Apr 19, 2017)
52-week high$12.6611
52-week low$12.6420
Median price$11.0714
Average price$11.1049
Largest weekly change+6.0% (Jan 10, 2018)
Weeks tracked501
Tracking sinceApr 19, 2017

Price History

1W

+0.1%

1M

+0.1%

3M

+0.1%

6M

+0.0%

1Y

+0.0%

3Y

+9.1%

5Y

+17.7%

All

+35.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 15%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of EUCRISA 2% OINTMENT?

The current National Average Drug Acquisition Cost (NADAC) for EUCRISA 2% OINTMENT, manufactured by Pfizer Inc., is $12.6535 per GM (NDC 55724021121), effective Nov 18, 2026.

How has the price of EUCRISA 2% OINTMENT changed over time?

Over the history we have for it, the NADAC for EUCRISA 2% OINTMENT has risen 35.2%. It has been tracked across 501 weekly CMS publications since Apr 19, 2017.

What are the highest and lowest recorded NADAC prices for EUCRISA 2% OINTMENT?

Since Apr 19, 2017, the NADAC for EUCRISA 2% OINTMENT has ranged from a low of $9.3589 (Apr 19, 2017) to a high of $12.6872 (May 14, 2025), with a median of $11.0714 per GM.

Are there cheaper alternatives to EUCRISA 2% OINTMENT?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EUCRISA 2% OINTMENT, is $10.6927 per GM — about 15% below EUCRISA 2% OINTMENT.

Who manufactures EUCRISA 2% OINTMENT?

EUCRISA 2% OINTMENT (NDC 55724021121) is labeled by Pfizer Inc., and CMS classifies it as a brand product.